Replies to post #136253 on NanoViricides Inc. (NNVC)

[Nanotoday]

You are conflating TA with Facts. They are not the same. Facts are provable whereas analysis is opinion (regardless of how educated the guess may be) based on current data.

[Its_lose_not_loose]

Second part of statement infers subjective opinion, contradictory to the use of the word "facts" (which by definition is objective) in the first part of the sentence.

One can listen to facts, at least as I see them, or not.

[mike41]

Since the stock price for NNVC is resilient, it may be more informative to pose possible reasons rather than presume.

1) With all the work that has been done to scale up at the Shelton facility, they may be closer than you think to an effective scale up process.

2) The one cide for VZV and HSV strategy has legs if scaling up comes through.

3) We still have not heard the final results from Dr Moffat's lab and there is no reason to think that they won't be good.

4) Things can happen very quickly, Diwan finally picks his lead cide formula, a pre-IND is filed, registration of cGMP is filed, tox starts.

6) Short covering is canceling out year end tax loss selling.

7) Potential deal of some sort with big pharma.

8) All of the above.

9) There is a reason the stock price is so resilient, we just don't know what it is, yet.


I also believe the timing of settling up early with Dr Milton Bonuik was no accident.